TSDD TSDD 27 Dec 2023 Paid | Monthly | $3.87 Per Share |
TSDD TSDD 27 Dec 2023 Paid | Monthly | $3.87 Per Share |
NASDAQ (NMS) Exchange | US Country |
This actively managed exchange-traded fund (ETF) is designed to offer investors a unique investment approach by attempting to replicate twice the inverse (-200%) of the daily percentage change of an underlying stock. Rather than holding the underlying stock directly, the fund enters into a swap agreement related to the stock's performance. This financial instrument is geared towards experienced investors looking for a way to potentially profit from or hedge against the daily declines in the stock's value. It's important to note that this strategy, aiming to generate the inverse daily performance for a single day, is complex and carries a high level of risk, including the potential for significant losses. Investors should carefully consider their investment objectives and the risks involved before investing in this type of ETF.
This service involves the active management of an exchange-traded fund that seeks to achieve 2 times the opposite of the daily performance of the underlying stock. The management team employs strategies including the use of swap agreements to aim for the desired inverse results. This service is ideal for investors looking to engage in sophisticated trading strategies to potentially capitalize on the negative movements of a specific stock or market sector.
As part of its strategy to replicate the inverse daily percentage change of the underlying stock, the fund utilizes swap agreements. A swap agreement is a contract between the fund and a counterparty where the two parties exchange the returns of the underlying stock for the returns that are inversely related to the stock's performance, multiplied by a factor of -200%. This financial instrument is crucial for the fund's aim to mirror the inverse performance of the underlying stock on a daily basis. It's a sophisticated financial derivative that plays a key role in the fund's operation and strategy.